Kelly Financial Services LLC Regeneron Pharmaceuticals, Inc. Transaction History

Kelly Financial Services LLC

  • $258 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jul 17, 2024
SELL
$543.48 - $670.97 $2,173 - $2,683
-4 Closed
0 $0
Q3 2021

Jul 17, 2024
SELL
$574.03 - $680.96 $1.28 Million - $1.52 Million
-2,230 Reduced 99.82%
4 $2.42 Million
Q2 2021

Jul 17, 2024
BUY
$472.8 - $558.54 $1.05 Million - $1.24 Million
2,221 Added 17084.62%
2,234 $4,000
Q1 2021

Jul 17, 2024
BUY
$446.73 - $548.2 $5,807 - $7,126
13 New
13 $6.15 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email